ATAI LIFE SCIENCES NV (9VC.DE) Stock Analyst Earnings Estimates
FRA:9VC - Deutsche Boerse Ag - NL0015000DX5 - Common Stock - Currency: EUR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 230K -98.87% | 314K 36.52% | 308K -1.91% | 1.611M 423.05% | 218.576K -86.43% | 57.222M 26,079.48% | 200.08M 249.66% | 506.16M 152.98% | 826.04M 63.20% | 1.13B 36.80% | 1.725B 52.65% | |
| EBITDA YoY % growth | -144.26M -19.94% | -121.952M 15.46% | -99.318M 18.56% | -111.282M -12.05% | -108.732M 2.29% | -134.64M -23.83% | -103.785M 22.92% | -65.331M 37.05% | 126.43M 293.52% | 231.44M 83.06% | 1.045B 351.52% | |
| EBIT YoY % growth | -144.43M -20.03% | -122.271M 15.34% | -99.791M 18.39% | -102.144M -2.36% | -133.113M -30.32% | -125.591M 5.65% | 13.698M 110.91% | 220.9M 1,512.64% | 473.12M 114.18% | 525.12M 10.99% | 1.03B 96.15% | |
| Operating Margin | -62,795.65% | -38,939.81% | -32,399.68% | -6,340.42% | -60,900.09% | -219.48% | 6.85% | 43.64% | 57.28% | 46.47% | 59.71% | |
| EPS YoY % growth | -0.98 -14.66% | -0.29 70.41% | -0.93 -220.69% | -0.48 47.90% | -0.51 -5.56% | -0.44 14.25% | 0.90 304.65% | 1.62 80.68% | 2.90 78.62% | 0.89 -69.37% | 3.50 294.25% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 66.94% | -0.11 32.71% | -0.11 52.72% | -0.11 25.20% |
| Revenue Q2Q % growth | -100.00% | -100.00% | 191.25K 3,925.00% | -100.00% |
| EBITDA Q2Q % growth | -25.041M 1.66% | -25.449M -13.85% | -24.225M 6.13% | N/A |
| EBIT Q2Q % growth | -23.928M 6.64% | -24.751M -9.51% | -27.072M -1.44% | -27.912M -44.85% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -0.15 11.76% | -0.18 | 0.03 | 17.15% |
| Q4 2024 Q2Q % growth | -0.24 -100.00% | -0.15 | -0.09 | -62.27% |
| Q3 2024 Q2Q % growth | -0.16 -164.00% | -0.16 | 0.00 | -0.12% |
| Q2 2024 Q2Q % growth | -0.36 -71.43% | -0.17 | -0.19 | -115.21% |
| Q1 2024 Q2Q % growth | -0.17 19.05% | -0.19 | 0.02 | 8.42% |
| Q4 2023 Q2Q % growth | -0.12 57.14% | -0.17 | 0.05 | 27.97% |
| Q3 2023 Q2Q % growth | 0.25 213.64% | -0.21 | 0.46 | 221.68% |
| Q2 2023 Q2Q % growth | -0.21 12.50% | -0.21 | 0.00 | 0.75% |
| Q1 2023 Q2Q % growth | -0.21 12.50% | -0.22 | 0.01 | 3.11% |
| Q4 2022 Q2Q % growth | -0.28 54.84% | -0.23 | -0.05 | -20.56% |
| Q3 2022 Q2Q % growth | -0.22 -4.76% | -0.24 | 0.02 | 7.35% |
| Q2 2022 Q2Q % growth | -0.24 35.14% | -0.24 | 0.00 | -1.97% |
| Q1 2022 Q2Q % growth | -0.24 -3,237.25% | -0.25 | 0.01 | 3.53% |
| Q4 2021 Q2Q % growth | -0.62 | -0.24 | -0.38 | -161.44% |
| Q3 2021 Q2Q % growth | -0.21 | -0.22 | 0.01 | 4.20% |
| Q2 2021 Q2Q % growth | -0.37 | -0.19 | -0.18 | -97.61% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -5K -127.78% | 306K | -311K | -101.63% |
| Q3 2024 Q2Q % growth | 40K -54.02% | 40K | % | |
| Q2 2024 Q2Q % growth | 273K 58.72% | 273K | % | |
| Q1 2024 Q2Q % growth | -100.00% | % | ||
| Q4 2023 Q2Q % growth | 18K -55.00% | 191.352K | -173.352K | -90.59% |
| Q3 2023 Q2Q % growth | 87K 335.00% | 5.396K | 81.604K | 1,512.37% |
| Q2 2023 Q2Q % growth | 172K 1.18% | 6.457K | 165.543K | 2,563.94% |
| Q4 2022 Q2Q % growth | 40K -82.61% | 114.75K | -74.75K | -65.14% |
| Q3 2022 Q2Q % growth | 20K -92.59% | 20K | % | |
| Q1 2022 Q2Q % growth | -100.00% | % | ||
| Q1 2021 Q2Q % growth | 19.88M | 20.284M | -404K | -1.99% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -4.17% | 36.94% | 9.52% | 36.03% |
| Revenue | N/A | N/A | -20.05% | 215.88% |